Belizatinib/ceritinib/crizotinibDevelopement of multi-drug resistance in non small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1658卷 / 1期
关键词：
D O I：
10.1007/s40278-017-32278-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：81 / 81
相关论文
共 50 条
  • [41] Organizing pneumonia resembling disease progression in a non-small-cell lung cancer patient receiving ceritinib A case report
    Lim, Sun M.
    An, Hee-Jung
    Park, Hyung S.
    Kwon, Hyeong J.
    Y. Kim, Eun
    Hur, Jin
    Moon, Yong W.
    MEDICINE, 2018, 97 (31)
  • [42] Alectinib/ceritinib/crizotinibAcquired drug resistance: case report
    Reactions Weekly, 2021, 1849 (1) : 25 - 25
  • [43] AfatinibAfatinib resistance, transformation from non small cell lung cancer to small cell lung cancer and hand/foot syndrome: case report
    Reactions Weekly, 2017, 1675 (1) : 19 - 19
  • [44] Mechanism of drug resistance in non-small-cell lung cancer
    Nature Clinical Practice Oncology, 2005, 2 (4): : 177 - 177
  • [45] Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
    Tekchandani, Pawan
    Das Kurmi, Balak
    Paliwal, Shivani Rai
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2017, 17 (18) : 1793 - 1810
  • [46] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shen, Liang
    Ji, Hong-Fang
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (26): : 2537 - 2537
  • [47] IS THE CANCER STEM CELL POPULATION "A PLAYER" IN MULTI-DRUG RESISTANCE?
    Drewa, Tomasz
    Styczynski, Jan
    Szczepanek, Joanna
    ACTA POLONIAE PHARMACEUTICA, 2008, 65 (04): : 493 - 500
  • [48] Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer
    Shaw, Alice T.
    Kim, Dong-Wan
    Mehra, Ranee
    Tan, Daniel S. W.
    Felip, Enriqueta
    Chow, Laura Q. M.
    Camidge, D. Ross
    Vansteenkiste, Johan
    Sharma, Sunil
    De Pas, Tommaso
    Riely, Gregory J.
    Solomon, Benjamin J.
    Wolf, Juergen
    Thomas, Michael
    Schuler, Martin
    Liu, Geoffrey
    Santoro, Armando
    Lau, Yvonne Y.
    Goldwasser, Meredith
    Boral, Anthony L.
    Engelman, Jeffrey A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (13): : 1189 - 1197
  • [49] THE SUPPRESSION OF MULTI-DRUG RESISTANCE IN THE SECONDARY DRUG RESISTANCE CELL LINE OF OVARIAN CANCER
    Park, C. M.
    Kim, S. Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 58 - 58
  • [50] Ceritinib: an orphan drug for ALK positive non-small cell lung cancer with robust clinical evidence
    Rolfo, Christian
    Arias, David
    Gandia, Jose Ferri
    Manca, Paolo
    Santos, Edgardo
    Raez, Luis E.
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (12): : 991 - 997
12345